Benzinga | Nov 6, 2020 11:26AM EST

Morgan Stanley Maintains Equal-Weight on Global Blood Therapeutics, Lowers Price Target to $67

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and lowers the price target from $68 to $67.